Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 20, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, September 19, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Brian Abrahams Reiterated (BIIB) at Buy and Held Target at $292 on, Sep 19th, 2024
Brian Abrahams of RBC Capital, Reiterated "Biogen Inc." (BIIB) at Buy and Held Target at $292 on, Sep 19th, 2024.
Brian has made no other calls on BIIB in the last 4 months.
There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $190 on, Friday, August 2nd, 2024
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $210 on, Friday, August 2nd, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Decreased Target to $225 on, Friday, August 2nd, 2024
These are the ratings of the 8 analyists that currently disagree with Brian
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $292 on, Monday, September 9th, 2024
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $285 on, Wednesday, September 4th, 2024
- Salim Syed of "Mizuho" Maintained at Buy with Decreased Target to $251 on, Tuesday, August 6th, 2024
- Srikripa Devarakonda of "Truist Securities" Reiterated at Strong Buy with Decreased Target to $302 on, Monday, August 5th, 2024
- George Farmer of "Scotiabank" Maintained at Buy with Decreased Target to $244 on, Friday, August 2nd, 2024
- Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $294 on, Monday, July 29th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $313 on, Friday, July 12th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, May 23rd, 2024
